Vicus Therapeutics
2005
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Angel
LATEST DEAL TYPE
$755K
LATEST DEAL AMOUNT
Description
Provider of cancer treatment therapies. The company offers lung cancer treatment therapies for advanced stage cancer patients.
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
- 55 Madison Avenue
- Suite 400
- Morristown, NJ 07960
- United States
+1 (973) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Vicus Therapeutics’s full profile, request a free trial.
Vicus Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Angel (individual) | 12-Aug-2010 | $755K | 00.000 | Completed | Startup | |
| 3. Angel (individual) | 09-Jul-2009 | 00000 | 00.000 | Completed | Startup | |
| 2. Angel (individual) | 06-Aug-2008 | $800K | $1.6M | Completed | Startup | |
| 1. Angel (individual) | 27-Jul-2007 | $800K | $800K | Completed | Startup |
Vicus Therapeutics Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| John Maki | President, Board Member & Chief Executive Officer | ||
| Newell Bascomb Ph.D | Chief Operating Officer & Executive Vice President |
Vicus Therapeutics Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Arch Meredith | Self | Board Member | 000 0000 | |
| Charles Crocker | Self | Board Member | 000 0000 | |
| Jim Erbs | Vicus Therapeutics | Board Member | 000 0000 |